OB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc.
|
|
- Jewel Bennett
- 6 years ago
- Views:
Transcription
1 OB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc.
2 Napa, California
3 IMPORTANT SAFETY INFORMATION ABOUT EVAMIST: WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, BREAST CANCER, PROBABLE DEMENTIA and UNINTENTIONAL SECONDARY EXPOSURE TO ESTROGEN. *INCREASED RISK OF ENDOMETRIAL CANCER IN WOMEN USING UNOPPOSED ESTROGEN. *ESTROGEN SHOULD NOT BE USED FOR PREVENTION OF CARDIOVASCULAR DISEASE OR DEMENTIA *THE WOMEN S HEALTH INITIATIVE REPORTED INCREASED RISK OF STROKE AND DVT WITH ESTROGEN USE *THE WHI ESTROGEN PLUS PROGESTIN STUDY REPORTED INCREASED RISKS OF INVASIVE BREAST CANCER
4 Transdermal Estrogen Is used to treat symptoms, not for prevention of cardiac disease Is NOT the same type of Estrogen used in the WHI Is NOT the type of Estrogen that increases risk for DVT and stroke
5 GOALS: (1): To be able to clearly define menopause, and the most common changes likely to occur as well as symptoms menopausal women are likely to have (2): To define the hormonal changes that occur, and what treatments are available for menopausal symptoms (3): To become familiar with some of the older and the more recent studies on the safety and success rates of various menopausal treatments (4): To compile a list of alternatives to hormones to manage symptoms
6 WHAT IS MENOPAUSE?: TWELVE CONSECUTIVE MONTHS AROUND THE AGE OF FIFTY with NO PERIODS WITH or WITHOUT SYMPTOMS
7 ALWAYS ALWAYS ALWAYS EVALUATE POST-MENOPAUSAL BLEEDING
8 WHAT HAPPENS IN MENOPAUSE?: Progesterone levels decline (lack of ovulation) Estrogen levels decline (ovaries shut down) Irregular periods > fewer periods No periods/ Hot flashes/ Insomnia/symptoms Ultimately, NO periods
9 MENOPAUSE PLANNING: LACK OF ESTROGEN: INSOMNIA HOT FLASHES MOOD SWINGS BLADDER PROBLEMS DEPRESSION/ANXIETY VAGINAL DRYNESS PAINFUL INTERCOURSE LACK OF ENERGY THINNING HAIR,DRY SKIN
10 LACK OF PROGESTERONE: BREAST TENDERNESS BLOATING PMS-LIKE FEELING INSOMNIA,POOR SLEEP ANXIETY
11 LACK OF TESTOSTERONE: LOW ENERGY LOW LIBIDO ACHES AND PAINS IN THE JOINTS WEAK MUSCLES FATIGUE
12 WHO CANNOT USE ESTROGEN? History of an Estrogen-related cancer History of an Estrogen-related blood clot Previous bad side effects or allergic reaction to an Estrogen-related product Unexplained vaginal bleeding Clotting abnormality/liver issues/hypercoagulable...smokers?
13 HORMONES are FOR SYMPTOMS In the N.I.H. -sponsored State of the Science Conference on the Management of Menopausal Symptoms in March of 2005, it was concluded that for vasomotor symptoms, night sweats and vaginal dryness only Estrogen therapy is conclusively associated with benefit.
14 The Women s Health Initiative Launched in 1991 Clinical trials and observational over 160,000 women oral conjugated equine Estrogen and Medroxyprogesterone, a Progestin Looking for cardiovascular benefit.
15 The WOMEN S HEALTH INITIATIVE One arm stopped in 2002 (CEE+P) Cardiovascular events outweighed benefits Other arm (CEE only) stopped due to increased stroke risk (no increase in breast ca or heart disease)
16 WOMEN s HEALTH INITIATIVE: Concluded that the long-standing opinion that supplementation with Estrogen would REDUCE cardiovascular risk was WRONG There was an increase in cardiovascular events in this study (which used only Conjugated Equine Estrogen and Medroxyprogesterone orally) The study was abruptly halted because of these findings.
17 After The WHI Most women discontinued their hormones They were then looking for other ways to treat their symptoms Many new studies came out looking at different types of hormones MANY OF THEIR CONCLUSIONS WERE INCORRECT
18 What was wrong with the WHI? enopause is 51, but average age in the WHI was 63; distant f The study did not address menopausal symptoms Large dropout rate dy was disease prevention but most women take hormones
19 WHI conclusions: No increase in all-cause mortality in women on HRT during either the treatment period or the long-term follow up 29% fewer hip fractures in women on hormone replacement, with 21% fewer hip fractures in women age 60 & above ONE more breast cancer case per 1000 women in the E+P arm of the study
20 The K.E.E.Ps Trial 2012 The KRONOS Early Estrogen Prevention Study Presented at the North American Menopause Society s 2012 meeting. Studied by the Kronos Longevity Research Institute. Multicenter, randomized study >700 women over 4 years double-blinded placebo-controlled Low dose oral Premarin or Transdermal Estradiol and cyclic monthly Progesterone
21 KEEPS Three Arms Oral Premarin Transdermal Estradiol Estrogen groups received cyclic Placebo Progesterone
22 EEPS Both hormone therapy groups had reduced symptoms of menopause, including hot flashes and night sweats Also had favorable effects on bone density compared to the placebo group. Improvements in lubrication and decreased pain with intercourse In the Transdermal group: improved arousal and desire but not in the oral Conjugated Estrogens group Coronary artery calcium and carotid ultrasounds showed a trend toward less progression of deposits in the groups on HT compared to placebo
23 K.E.E.P.s Study --No differences in the rates of Breast Cancer, Endometrial Cancer, M.I., Stroke or DVT --Small study Population, difficult to make definitive conclusions --Younger population may have been key since this study population were all between 42 and 59 years of age when they entered the study. --TYPE of Estrogen and Progesterone were different than what had been used in the WHI
24 Effect of Hormone Replacement Therapy on Cardiovascular Events in Recently Postmenopausal Women Randomized controlled trial of >1000 Danish women Recently menopausal, age Half received Hormone replacement, (17-B estradiol/norethistrone); half none (controls) After 10 yrs of treatment women on HRT had a significantly reduced risk of mortality, heart failure and MI British Medical Journal 2012:345:e6409 October 9
25 Danish study: Hormone therapy started in recently menopausal women and continued for a long period of time (>10 yrs) does not increase or provoke adverse cardiovascular events
26 STANFORD Medical School 2014 Estradiol but not Premarin, Preserves Key Brain Regions in Postmenopausal Women at risk for Dementia ---several dozen San Francisco Bay area women ---under 60, in robust health ---Initiated hormone therapy within a year of their last menstrual cycle ---at heightened risk for dementia PLOS 1: March 12, 2014
27 Stanford Medical School Study CONCLUSIONS: ---When women who started on ESTRADIOL therapy within a year of menopause stayed on the regimen, metabolic activity in regions of the brain was preserved ---It declined significantly in those who stopped using the Estradiol ---PREMARIN appeared to accelerate the brain regions metabolic decline ---If a PROGESTIN (as in the WHI) was added to the beneficial Estradiol regimen, it seemed to negate the beneficial effect of the Estradiol
28 CHOIICE STUDY: 2011 Dr Kenna Stephenson Compounded Bioidentical Hormones: Immune, Inflammatory and Cardiovascular Effects ---A 3-year study undertaken to look at the effects of transdermal hormones on: ~Fasting Glucose ~Triglycerides ~C-Reactive Protein levels Found Improvement in all of these, concluding that Bioidentical hormones through the skin may have a benefit in reducing cardiovascular risk and prevention of cardiovascular disease. Although there is MUCH controversy about the use of Compounded products, there may be some benefit. Small study, 75 in intervention, 75 in control University of Texas Health Science Center
29 The ESTHER Study HORMONE THERAPY AND VENOUS THROMBOEMBOLISM AMONG POSTMENOPAUSAL WOMEN Published in the Journal CIRCULATION --Multicenter case controlled study --VTE among postmenopausal women age between 1999 and 2005 in France who were on various hormonal regimens --CONCLUSION: Oral, but NOT Transdermal Estrogen was associated with an increased risk for VTE ---NO significant increase in VTE with Micronized, BioIdentical Progesterone Circulation:2007, Feb 20;115(7):840-5
30 ESTHER Study Multicenter, case control study 271 cases of VTE from hospital records & 610 controls, matched for age and admission date NO significant association of VTE with transdermal Estrogens, or with Micronized Progesterone, but positive association with oral Estrogen Circulation:2007, Feb 20;115(7):840-5
31 ELITE TRIAL Early vs Late Intervention Trial with Estradiol >600 healthy postmenopausal women, stratified according to time since menopause Either 17B-estradiol + progesterone or placebo Primary outcome: rate of change of carotid artery intimate-media thickness Secondary outcome: assessment of coronary atherosclerosis by cardiac CT NEJM 2016; 374:
32 ELITE TRIAL Early vs Late Intervention Trial with Estradiol Among women who were less than 6 years from menopause, mean intimal thickness was statistically less in the estrogen group vs placebo (.0078 vs.0044mm, p=.008) Among women who were >10 years past menopause, rates of intimal thickening were similar in placebo vs estrogen group NEJM 2016; 374:
33 ELITE TRIAL Early vs Late Intervention Trial with Estradiol In conclusion, we found that the effects of estradiol (with or without progesterone) on the progression of atherosclerosis differed according to the time of initiation of therapy, with benefit noted when it was initiated in women who were less than 6 years past menopause but not when it was initiated in women who were 10 or more years past menopause. NEJM 2016; 374:
34 THE RULES of Hormone Replacement HORMONE THERAPY IS FOR SYMPTOMS IF A PATIENT HAS AN INTACT UTERUS, PROGESTERONE MUST BE PRESCRIBED ALONG WITH ESTROGEN ESTROGEN SHOULD GO THROUGH THE SKIN IF POSSIBLE KNOW IF YOUR PATIENT IS IN MENOPAUSE
35 The Rules: IF THE SYMPTOMS ARE ONLY VAGINAL, TREAT VAGINALLY (VAGIFEM, ESTRACE cream, ESTRING, Vaginal DHEA, oral Osphena, CO2 laser for the vagina) TAKE A GOOD HISTORY AND DO AN EXAM Evaluate all bleeding (IS THERE A REASON THIS PATIENT CANNOT USE HRT?) PAY ATTENTION TO THE TIME THEORY
36 Treatment forvaginal symptoms 1-Estrogen products: Premarin cream, Estrace cream, Vagifem and Yuvafem Pills and Estring vaginal ring 2-OSPHENA- S.E.R.M. 60 mg PO Qday 3-Vaginal/vulvar CO2 fractionated laser 4- Vaginal DHEA: Intrarosa Recently FDA approved 5-Lubricants, ph correctors, Protectants
37 NORTH AMERICAN MENOPAUSE SOCIETY on CONTINUING USE of SYSTEMIC HORMONE THERAPY AFTER AGE NAMS stated that hormone therapy is the most effective treatment for symptoms of menopause Initiate within 10 yrs of menopause (Ideally 5-7) No contraindications, no reason to stop Benefits of menopause symptom relief outweigh the risks..
38 ALTERNATIVES BRISDELLE--SSRI low dose 10 mg for flashes VENLAFAXINE SSNRI for hot flashes ESTROVERA- Rhubarb plant, studies have shown hot flash relief CATAPRES--patch or pill; many incremental doses RELIZEN- Bee pollen OSPHENA--SERM for vaginal dryness/dyspareunia
39 Conclusions: Evidence shows the benefits of using HRT often outweigh the risks. Most women are candidates for HRT to treat their symptoms; rule out those who are not and offer alternatives Time Theory-must initiate near menopause Vaginal symptoms require vaginal treatment
40 THANK YOU Dr Rebecca Levy-Gantt Premier ObGyn Napa Inc premierobgynnapa.com
Women s Health: Managing Menopause. Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School
Women s Health: Managing Menopause Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School Disclosures I have no conflicts of interest. Learning Objectives 1. Apply strategies to help
More informationLearning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories
Learning Objectives Identify common symptoms of the menopause transition Understand the risks and benefits of hormone replacement therapy (HRT) Be able to choose an appropriate hormone replacement regimen
More informationMenopausal Management: What Has Changed?
Menopausal Management: What Has Changed? Julia V. Johnson, M.D. Professor and Chair, OB/GYN University of Massachusetts Medical School UMass Memorial Medical Center Conflicts of Interest None Learning
More informationMENOPAUSE. I have no disclosures 10/11/18 OBJECTIVES WHAT S NEW? WHAT S SAFE?
MENOPAUSE WHAT S NEW? WHAT S SAFE? I have no disclosures Sara Whetstone, MD, MHS OBJECTIVES To describe risks of HT by age and menopause onset To recommend specific HT regimen for women who undergo early
More informationAppendix: Reference Table of HT Brand Names
Appendix: Reference Table of HT Brand Names This is a full reference table in alphabetical order, of Brand Name drugs used in HT. It is the basis for prescription advice throughout this handbook. Drug
More informationWHI Estrogen--Progestin vs. Placebo (Women with intact uterus)
HORMONE REPLACEMENT THERAPY In the historical period it was commonly held that estrogen had two principal benefits to postmenopausal women: 1) To alleviate the constitutional symptoms related to the climacteric
More informationMenopause management NICE Implementation
Menopause management NICE Implementation Dr Paula Briggs Consultant in Sexual & Reproductive Health Southport and Ormskirk NHS Hospital Trust Why a NICE guideline (NG 23) Media reports about HRT have not
More information2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK
2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK WHI the only large, long-term RCT of HT in women aged 50 to 79 years, Drug trail
More informationBy J. Jayasutha Lecturer Department of Pharmacy Practice SRM College of Pharmacy SRM University
By J. Jayasutha Lecturer Department of Pharmacy Practice SRM College of Pharmacy SRM University Cessation of menstruation as a result of the aging process of or surgical removal of the ovaries; change
More informationPost-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018
Post-menopausal hormone replacement therapy Evan Klass, MD May 17, 2018 Are we really still talking about this? Are we really still talking about this? 1960-1975- estrogen prescriptions doubled. Pharma
More informationSERMS, Hormone Therapy and Calcitonin
SERMS, Hormone Therapy and Calcitonin Tiffany Kim, MD Clinical Fellow VA Advanced Women s Health UCSF Endocrinology and Metabolism I have nothing to disclose Thanks to Clifford Rosen and Steven Cummings
More informationJames H. Liu, M.D. Arthur H. Bill Professor Chair of Reproductive Biology Dept of Obstetrics and Gynecology
Disclosure Estrogen Therapy After Postmenopausal Hysterectomy: Issues, Challenges, Risks/Benefits James H. Liu, M.D. Arthur H. Bill Professor Chair of Reproductive Biology Dept of Obstetrics and Gynecology
More informationMenopausal Symptoms. Hormone Therapy Products Available in Canada for the Treatment of. Physician Desk Reference - 3rd Edition
Hormone Therapy Products Available in Canada for the Treatment of Menopausal Symptoms Physician Desk Reference - 3rd Edition A clinical resource provided to you by: The Society of Obstetricians and Gynaecologists
More informationKathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School
Update: Hormones and Cardiovascular Disease in Women Kathryn M. Rexrode, MD, MPH Assistant Professor Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Overview Review
More informationOVERVIEW OF MENOPAUSE
OVERVIEW OF MENOPAUSE Nicole Budrys, MD, MPH Reproductive Endocrinology Michigan Center for Fertility and Women s Health Presented at SEMCME March 13,2019 Objectives Define menopause Etiology of menopause
More informationMenopausal Symptoms The Who: Hot flashes are reported by as many as 75% of perimenopausal women in the U.S.
Menopausal Hormone Therapy: The Who, What, Where, When and Why Laurie Birkholz, MD, NCMP Knowledge of Clinical Trials Regarding Hormone Therapy and Likelihood of Prescribing Hormone Objective: The aim
More informationUPDATE: Women s Health Issues
UPDATE: Women s Health Issues Renee B. Alexis, MD, MBA, MPH, FACOG Associate Professor Department of OBGYN Kiran C. Patel College of Osteopathic Medicine Disclosure of Conflicts of Interest I have no financial
More informationHRT in Perimenopausal Women. Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College
HRT in Perimenopausal Women Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College 1 This is the Change But the CHANGE is not a disease 2 Introduction With a marked increase in longevity, women now
More informationHRT & Menopause Where Do We Stand Now?
HRT & Menopause Where Do We Stand Now? Mrs. SY Hussain Consultant Gynaecologist The Holly Private Hospital Spire Roding Hospital The Wellington Hospital Discussion Points Discuss Recommendations made by
More informationHORMONES AND YOUR HEALTH Charlie Tucker Pharm. D
HORMONES AND YOUR HEALTH Charlie Tucker Pharm. D All of the hormones in your body are designed to work together. This is God s plan. Therefore, if one is altered, or deficient, it will affect the actions
More informationDifference between vagifem and yuvafem
Difference between vagifem and yuvafem Generally, when estrogen is prescribed for a postmenopausal woman with a uterus, a progestin should also be considered to reduce the risk of endometrial cancer. Estrogen-alone
More informationHOW TO MAKE SENSE OF MENOPAUSE. by Steven. F. Hotze, M.D.
HOW TO MAKE SENSE OF MENOPAUSE by Steven. F. Hotze, M.D. INTRODUCTION Dr. Hotze is founder of Hotze Health & Wellness Center and author of the book Hormones, Health, and Happiness. He has enabled thousands
More informationpresents with Ken Sekine, MD
presents Pioneering Technologies For Pellet Hormone Therapy Lifestyle Based Medicine A Primer for Clinicians with Ken Sekine, MD Dr. Sekine is a board certified OB-GYN who has been in private practice
More informationLessons from the WHI HT Trials: Evolving Data that Changed Clinical Practice
Lessons from the WHI HT Trials: Evolving Data that Changed Clinical Practice JoAnn E. Manson, MD, DrPH, FACP Chief, Division of Preventive Medicine Interim Executive Director, Connors Center Brigham and
More informationA Practitioner s Toolkit for the Management of the Menopause
Medicine, Nursing and Health Sciences A Practitioner s Toolkit for the Management of the Menopause Developed by the Women s Health Research Program School of Public Health and Preventive Medicine Monash
More informationManaging menopause in Primary Care and recent advances in HRT
Managing menopause in Primary Care and recent advances in HRT Raj Saha, MD, DMRT, FRCOG Consultant Gynaecologist Heart of England NHS Foundation Trust rajsaha1@yahoo.co.uk Content of today s talk Aims
More informationMenopause. Medicines To Help You
Medicines To Help You Menopause Use this guide to help you talk to your doctor, pharmacist, or nurse about your hormone medicines. The guide lists all of the FDA-approved products now available to treat
More informationDisclosures. Learning Objectives. Effects of Hormone Therapy on the Metabolic Syndrome and Cardiovascular Disease. None
Effects of Hormone Therapy on the Metabolic Syndrome and Cardiovascular Disease Micol S. Rothman, MD Associate Professor of Medicine Endocrinology, Diabetes and Metabolism Clinical Director Metabolic Bone
More informationSouthern California Center for Sexual Health and Survivorship Medicine Inc, Newport Beach, CA 3
The WISDOM survey: Physicians Level of Comfort Prescribing Treatment for Vulvar and Vaginal Atrophy (VVA) Symptoms in Women with a Predisposition or History of Breast Cancer Lisa Larkin, MD 1 ; Michael
More informationSex, hormones and the heart
Sex, hormones and the heart Dr Louise Newson BSc(Hons) MBChB(Hons) MRCP FRCGP www.menopausedoctor.co.uk #IandA2017 Declaration I have had financial relationships (lecturer, writer, member of advisory boards
More information22/09/2014. Menopause Management. Menopause. Menopause symptoms
Menopause Management Dr Sonia Davison Jean Hailes for Women s Health Menopause Time of last menstrual period - average age 51 Premature Menopause: occurs before age 40 Perimenopause (menopause transition):
More informationDisclosures. Objec7ves 9/9/15. What Exactly are bio- iden7cal hormones and what should I tell my pa7ents? Christy Blanco, DNP, RN, WHNP- BC.
What Exactly are bio- iden7cal hormones and what should I tell my pa7ents? Christy Blanco, DNP, RN, WHNP- BC Disclosures None Objec7ves Discuss terminology of bio- iden7cal, synthe7c and natural hormones.
More informationMenopause & HRT. Rosie & Alex. Image:
Menopause & HRT Rosie & Alex Image: http://www.keepcalm-o-matic.co.uk/ Menopause The permanent cessation of menstruation for 12 months When does it happen? Average age 51 Image: Nature Medicine - 12, 612-613
More informationNorth American Menopause Society (NAMS)
North American Menopause Society (NAMS) 2012 Hormone Therapy Position Statement Cynthia B. Evans, MD Assistant Professor-Clinical Department of Obstetrics and Gynecology The Ohio State University College
More informationMs. Y. Outline. Updates of SERMs and Estrogen
Ms. Y Updates of SERMs and Estrogen Steven R. Cummings, MD, FACP San Francisco Coordinating Center CPMC Research Institute and UCSF Support from Lilly, Pfizer, Berlex 55 y.o. woman with mild hypertension
More informationCase Presentation. Learning Objectives. Case Presentation. Case Presentation
Learning Objectives To apply up to date information about the natural history of menopause to improve the care of individual women To counsel women about the risks and benefits of systemic hormone therapy
More informationBenton Franklin County Medical Society 31st Annual CME Seminar
Management of Current HT/ET and SERM Recommendations Benton Franklin County Medical Society 31st Annual CME Seminar February 21, 2015 Kennewick, Washington Spokane steoporosis Dr. Lynn Kohlmeier Lynn Kohlmeier,
More informationMENOPAUSAL HORMONE THERAPY 2016
MENOPAUSAL HORMONE THERAPY 2016 Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA NICE provides the National Health Service advice on effective, good value healthcare.
More informationEstrogen (conjugated estrogens & ethinyl estradiol) Addition to the List
Estrogen (conjugated estrogens & ethinyl estradiol) Addition to the List Note: Commonly prescribed medication. Literature question Is estrogen effective and safe? Are conjugated estrogens effective and
More informationHormone Restoration and Support
Hormone Restoration and Support As a doctor with a strong interest in functional medicine, I strive to help my patients to achieve optimal health in the best ways I know how. This encompasses a combined,
More informationBioIdentical Hormone Replacement Therapy for Women
BioIdentical Hormone Replacement Therapy for Women Bio-Identical Hormones are manufactured hormone products from soy or yam. They are changed in a laboratory so that the hormones produced are identical
More informationWhat's New in Menopause Management
Annual Review of Family Medicine December 10, 2015 San Francisco, CA What's New in Menopause Management Michael Policar, MD, MPH Clinical Professor of Ob, Gyn, and Repro Sciences UCSF School of Medicine
More informationMenopause - a summary of management
Page 1 of 5 Menopause - a summary of management Original article by: May Su Resources Menopause treatment algorithm The Jean Hales Foundation for women's heath. Menopause, a treatment algorithm. (Australian
More informationOhio Northern University HealthWise. Authors: Alexis Dolin, Andrew Duska, Hannah Lamb, Eric Miller, Pharm D Candidates 2018 May 2018
Women s Health Authors: Alexis Dolin, Andrew Duska, Hannah Lamb, Eric Miller, Pharm D Candidates 2018 May 2018 Let Your Body Empower You! National Women s Health Week Polycystic Ovary Syndrome Page 2 Breast
More informationManagement of Menopausal Symptoms
Management of Menopausal Symptoms Tammie Koehler DO, FACOG 1 Menopause Permanent cessation of menstruation that occurs after the loss of ovarian activity Determined to have occurred after 1 full year of
More informationDR REBECCA LEVY-GANTT HOT TOPICS IN OBGYN 2018
DR REBECCA LEVY-GANTT HOT TOPICS IN OBGYN 2018 2018 WHAT S NEW? Contraception: Long Acting reversible contraception Contraception: Birth control pills Vaginal dryness: Treatments Breast density: Diagnosis
More informationMenopause Matters. Equity Office Staff Seminar 14 November 2018
Menopause Matters Equity Office Staff Seminar 14 November 2018 1 What to expect at menopause How to manage symptoms Support at work Dr Janice Brown Medical lead, The University of Auckland NZ representative,
More informationApples & Oranges Synthetic vs. Bio-Identical Studied Under the Nation s Greats in Hormone Therapy! Salt Lake City Dr. Neal Rouzier Orlando Dr. Sangeeta Pati Naples Dr. Daved Rosensweet And finally Dallas
More information11/15/2017. Update on HRT. Highgate Private Hospital (Barnet Hospital) Women s Health. Menopause
Update on HRT Miss Moneli Golara Consultant Obstetrician and Gynaecologist MBBS, FRCOG Highgate Private Hospital (Barnet Hospital) E: lauren@medicaladministration.co.uk Women s Health Life expectancy of
More informationThe Swinging Pendulum in Menopause Management
The Swinging Pendulum in Menopause Management Heather Hirsch, MD, MS, NCMP Assistant Professor, Clinical Internal Medicine Division of General Internal Medicine & Center for Women s Health Director of
More informationThe Swinging Pendulum in Menopause Management
The Swinging Pendulum in Menopause Management Heather Hirsch, MD, MS, NCMP Assistant Professor, Clinical Internal Medicine Division of General Internal Medicine & Center for Women s Health Director of
More informationOrals,Transdermals, and Other Estrogens in the Perimenopause
Orals,Transdermals, and Other Estrogens in the Perimenopause Cases Denise Black, MD, FRCSC Assistant Professor, Obstetrics, Gynecology and Reproductive Sciences University of Manitoba 6/4/18 197 Faculty/Presenter
More informationPrior disclosures past 3 years Consultant for Pfizer University of Virginia received Grants/research support from TherapeuticsMD
Prior disclosures past 3 years Consultant for Pfizer University of Virginia received Grants/research support from TherapeuticsMD JoAnn V. Pinkerton, MD Professor of Obstetrics and Gynecology Director,
More informationEstrogen and progestogen therapy in postmenopausal women
Estrogen and progestogen therapy in postmenopausal women The Practice Committee of the American Society for Reproductive Medicine American Society for Reproductive Medicine, Birmingham, Alabama Hormone
More informationThe Estrogen Question
The Estrogen Question Hormone Therapy still offers the best relief for menopausal symptoms. Is it right for you? When 49-year-old Lee Ann Dodson heard the news that the Women's Health Initiative (WHI)
More informationMenopause: diagnosis and management NICE guideline NG23. Published November 2015
Menopause: diagnosis and management NICE guideline NG23 Published November 2015 1 Full title: Menopause : diagnosis and management Available at: http://www.nice.org.uk/guidance/ng23 Guideline published
More informationArizona Natural Medicine, L.L.C W. Ray Road, Suite 1, Chandler, AZ
MENOPAUSE: THE ROAD TO HARMONY by Dr. Sarv Varta Khalsa, N.M.D. Have you been feeling like your emotions are out of control lately? Do you feel irritable one minute, snapping impatiently at your family
More informationOBSTETRICS & GYNECOLOGY
JANUARY 2012 COMPOUNDING PHARMACY SOLUTIONS PRESCRIPTION COMPOUNDING WWW.CPSRXS. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: Female Sexual Arousal
More informationManaging menopause in Primary Care and recent advances in HRT
Managing menopause in Primary Care and recent advances in HRT Raj Saha, MD, DMRT, FRCOG PG Cert. Advanced Gynaecology Endoscopy Consultant Gynaecologist Heart of England NHS Foundation Trust Spire Parkway
More informationWhy do I need any hormone replacement? What is Menopause? What symptoms are treated by estrogen Injections?
1 Why do I need any hormone replacement? Women need replacement if they desire to: Delay the symptoms of aging Reverse depression and anxiety Regain libido Preserve skin and muscle tone Look younger Increase
More informationMenopause and HIV. Together, we can change the course of the HIV epidemic one woman at a time.
Menopause and HIV Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject What Is Menopause? Menopause: Point in time when a woman's menstrual periods
More informationMenopause & HRT. Matt McKenna Elliot Davis
Menopause & HRT Matt McKenna Elliot Davis Menopause Before age 40: Premature Menopause After 12 months clinical diagnosis made Depletion of Ovarian Follicles Oestrogen Progesterone LH FSH Spontaneous Amemorrhoea
More informationSummary of the risk management plan (RMP) for Senshio (ospemifene)
EMA/736568/2014 Summary of the risk management plan (RMP) for Senshio (ospemifene) This is a summary of the risk management plan (RMP) for Senshio, which details the measures to be taken in order to ensure
More informationAusPharm CE Hormone therapy 23/09/10. Hormone therapy
Hormone therapy Learning objectives: Assess options to address quality of life and health concerns of menopausal women Outline indications for hormone therapy Counsel women on the risks and benefits of
More informationHormone Replacement Therapy For Women
Hormone Replacement Therapy For Women Consultation Information www.urologyaustin.com Biological Aging and Hormones As we age, a natural degeneration and aging of organs causes the levels of our hormones
More informationMenopause Symptoms and Management: After Breast Cancer
Menopause Symptoms and Management: After Breast Cancer An Educational Webinar for Patients and their Caregivers Wen Shen, MD, MPH Division of Gynecologic Specialties July 27, 2018 1 Disclosure I have a
More informationNoven Receives FDA Approval of a New Indication with a New Dose for Minivelle (Estradiol Transdermal System)
Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle (Estradiol Transdermal System) Minivelle now approved for prevention of postmenopausal osteoporosis at all doses New 0.025
More informationUpdate on Menopause: What s New?
Karen Carlson, MD Current Clinical Issues in Primary Care 1 Update on Mepause: What s New? Karen Carlson, M.D. Massachusetts General Hospital Harvard Medical School Our agenda: Update on new data from
More informationSummary of the risk management plan (RMP) for Duavive (conjugated oestrogens / bazedoxifene)
EMA/679870/2014 Summary of the risk management plan (RMP) for Duavive (conjugated oestrogens / bazedoxifene) This is a summary of the risk management plan (RMP) for Duavive, which details the measures
More informationVirtual Mentor Ethics Journal of the American Medical Association November 2005, Volume 7, Number 11
Virtual Mentor Ethics Journal of the American Medical Association November 2005, Volume 7, Number 11 Clinical Pearl Post Women's Health Initiative Menopausal Women and Hormone Therapy by JoAnn V. Pinkerton,
More informationFemale Patient Questionnaire & History
Female Patient Questionnaire & History Name: (Last) (First) (Middle) Today s Date: Home Phone: Cell Phone: Work: E-Mail Address: Primary Care Physician s Name: May we contact you via E-Mail? ( ) YES (
More information5. Summary of Data Reported and Evaluation
326 5. Summary of Data Reported and Evaluation 5.1 Exposure data Combined estrogen progestogen menopausal therapy involves the co-administration of an estrogen and a progestogen to peri- or postmenopausal
More informationDINE AND LEARN ENDOCRINOLOGY PEARLS. Dr. Priya Manjoo, MD, FRCPC Endocrinology, Victoria, BC
DINE AND LEARN ENDOCRINOLOGY PEARLS Dr. Priya Manjoo, MD, FRCPC Endocrinology, Victoria, BC OUTLINE HRT and CVD HRT and Breast Cancer Osteoporosis When to treat How long to treat for Bisphosphonates BMD
More informationFemale New Patient Package
Female New Patient Package The contents of this package are your first step to restore your vitality. Please take time to read this carefully and answer all the questions as completely as possible. Thank
More informationVol-5 No-1 Jan-Mar 2012
"Women's Health" is also available at www.squarepharma.com.bd Editorial Board Dr. Omar Akramur Rab MBBS, FCGP, FIAGP Mohammad Hanif M. Pharm, MBA A.H.M. Rashidul Bari M. Pharm, MBA Executive Editor Chowdhury
More informationMenopause and HRT. John Smiddy and Alistair Ledsam
Menopause and HRT John Smiddy and Alistair Ledsam Menopause The cessation of menstruation Diagnosed retrospectively after 1 year of amenorrhoea Average age 51 in the UK Normal physiology - Menstruation
More informationMenopause and Post Gynecological Reproductive Care
Menopause and Post Gynecological Reproductive Care Nguyet-Cam Vu Lam, MD, FAAFP Associate Program Director St. Luke s Family Medicine Residency 1 Disclosure Dr. Nguyet-Cam Vu Lam has no conflict of interest,
More informationWe acknowledge the commitment you are making to your health and your
Dear patient, We acknowledge the commitment you are making to your health and your healing. We look forward to our time together. Please fill out the following registration form and questionnaire. We are
More informationTURNING DOWN THE HEAT ON MENOPAUSE. Erika Schwartz, M.D.
TURNING DOWN THE HEAT ON MENOPAUSE Erika Schwartz, M.D. www.drerika.com www.bhionline.org U.S. Census Bureau, 2004 US Female Population (000 s) 100000 90000 80000 70000 60000 50000 40000 30000 20000 10000
More informationFemale Patient Questionnaire & History
!! Female Patient Questionnaire & History Name: Today s Date: (Last) (First) (Middle) Date of Birth: Age: Weight: Occupation: Home Address: City: State: Zip: Home Phone: Cell Phone: Work: E-Mail Address:
More informationNew Treatments for Vaginal Health. Sarah Azad, MD El Camino Women s Medical Group
New Treatments for Vaginal Health There s Hope Sarah Azad, MD El Camino Women s Medical Group The Genitrourinary Syndrome of Menopause (GSM) Problems with genital health secondary to the changes that occur
More informationInnovative Nuclear Receptor Modulation Medicine
Innovative Nuclear Receptor Modulation Medicine Dale C Leitman, M.D., Ph.D. Isaac Cohen, O.M.D., Ph.D. October 2015 Corporate Mission Iaterion, Inc. is Developing Novel Pharmaceutical Nuclear Receptor
More informationData Shows Reduction in Frequency and Severity in Hot Flashes in as Early as 14 Days
Newly Published Menopause Study: Bioidentical and FDA Approved Divigel (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated with Menopause Data Shows Reduction
More informationBy Dr Rukhsana Hussain 5 th April 2016
By Dr Rukhsana Hussain 5 th April 2016 1. Is it indicated? Vasomotor symptoms (flushes/sweats) Vaginal atrophy Cycle control (In perimenopause consider low dose COCP (age
More informationBioidentical Hormones: Just the Facts
Bioidentical Hormones: Just the Facts Melissa McNeil, MD, MPH Professor of Medicine and Obstetrics, Gynecology and Reproductive Sciences Chief, Section of Women s Health University of Pittsburgh Disclosures!
More informationDr. Jack Monaco Safe Solutions for Menopause
Dr. Jack Monaco Safe Solutions for Menopause The following is taken from The Future of Health Now interview conducted by Ann Wixon with menopause and hormone expert, Dr. Jack Monaco. We have compiled the
More informationFemale New Patient Questionnaire
Patient Demographics First Name: Middle: Last Name: Home Phone: Cell Phone: Email: Address: SSN: City: State: Zip: Age: Date of Birth: Referred by: OBGYN: Occupation: Primary Care Physician: Marital Status:
More informationHRT. Responding to questions about. The Women s Health Initiative (WHI) is a large, CME Workshop. associated with combined
CME Workshop Responding to questions about HRT By Margaret Burnett, MD, BA(Hon), MA, CCFP, FRCPC The Women s Health Initiative (WHI) is a large, prospective, placebo-controlled trial sponsored by the National
More informationPresentation to the Clinical Utility of Treating Patients with Compounded Bioidentical Hormone Therapy
Presentation to the Clinical Utility of Treating Patients with Compounded Bioidentical Hormone Therapy March 5, 2019 Nese Yuksel, BScPharm, PharmD, FCSHP, NCMP Professor Faculty of Pharmacy and Pharmaceutical
More informationCurrent Topics in Hormone Replacement Therapy
Current Topics in Hormone Replacement Therapy Corey R. Babb, D.O., FACOOG, IF, NCMP Clinical Assistant Professor of Obstetrics and Gynecology Director of the Oklahoma State University Center for Women
More informationIf you would like bypass the presentation for the summary, right click on your mouse and go to slide # 138. Enjoy
Welcome This is an online version of a presentation given by Dr Keith Merritt. Its purpose is to give a balanced review of the risks, benefits and alternative treatments for the changes and symptoms of
More informationPotential dangers of hormone replacement therapy in women at high risk
ESC meeting, Stockholm, August 30, 16.30-18.00, 2010 Potential dangers of hormone replacement therapy in women at high risk Karin Schenck-Gustafsson MD, PhD, FESC Professor, Chief consultant Department
More informationMenopausal hormone therapy currently has no evidence-based role for
IN PERSPECTIVE HT and CVD Prevention: From Myth to Reality Nanette K. Wenger, M.D. What the studies show, in a nutshell The impact on coronary prevention Alternative solutions Professor of Medicine (Cardiology),
More informationFinancial Conflicts of Interest
Hormone Treatment of Menopausal Women: What Are the Data Telling Us (and Not Telling Us)? S. Mitchell Harman, M.D., Ph.D. Chief, Endocrine Division Phoenix VA Health Care System Clinical Professor, Medicine
More informationHORMONE THERAPY A BALANCED VIEW?? Prof Greta Dreyer
HORMONE THERAPY A BALANCED VIEW?? Prof Greta Dreyer -- PART 1 -- Definitions HRT hormone replacement therapy HT genome therapy ERT estrogen replacement therapy ET estrogen EPT estrogen progesterone therapy
More informationLET S START WITH (AND REMEMBER WE ARE TALKING ABOUT LOCAL E2) THERAPUTIC AGENTS: ARE THEY SAFE? Systemic HT/ET. Ospemifene. Local Estrogen Therapy
THERAPUTIC AGENTS: ARE THEY SAFE? Steven R. Goldstein, M.D. Professor of Obstetrics & Gynecology New York University School of Medicine Director of Gynecologic Ultrasound Co-Director of Bone Densitometry
More informationFederal Judge Sets Trial Dates for Two Hormone Replacement Therapy Cases in Arkansas Thousands More Pending
Federal Judge Sets Trial Dates for Two Hormone Replacement Therapy Cases in Arkansas Thousands More Pending Date Published: Sunday, February 12th, 2006 United States District Judge William Wilson in Little
More informationReal life issues & answers: The hormonal patient Defining best practice, 5 key issues & case study
Real life issues & answers: The hormonal patient Defining best practice, 5 key issues & case study Dr Louise Newson BSc(Hons) MBChB(Hons) MRCP FRCGP www.menopausedoctor.co.uk Case Number 1 - Claire Age
More information